Clinical trial finds no benefit from aspirin in preventing colorectal cancer recurrence
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
MedPage Today5d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
Campaign US5d
Exclusive: How Bayer cracked the retail media code
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
Bayer Leverkusen builds fresh momentum with 10-game winning run as Dortmund hits trouble
The two standout German teams from last season are on opposite trajectories as the pressure mounts in the Bundesliga and ...
Aspirin Industry Eyes $2.1 Billion Valuation by 2030: Tablets Will Continue to Dominate, Maintaining Around 60-65% Market Share
Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...
Fortune29d
A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
Bill Anderson has shaken up Bayer employees’ day-to-day since taking charge in 2023. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...
Business Insider29d
Bayer's CEO said budgets represent the worst of corporate bureaucracy. He decided to turn the process on its head.
Since becoming Bayer's CEO, Bill Anderson has introduced striking changes to the company, including an overhaul of its budget system, which he sees as the driving source of corporate bureaucracy.